Currently, the stock price of Fate Therapeutics Inc. (FATE) is $2.20. In the most recent trading session, the stock underwent a significant upswing, peaking at $2.3943 after opening at $2.36. The stock touched a low of $2.14 before closing at $2.36.
The stock market performance of Fate Therapeutics Inc. has been fairly unsteady. Over the last year, the company’s stock hit its highest at $27.28 on 09/16/22, while the lowest price during the same time frame was $2.33, recorded on 09/15/23.
52-week price history of FATE Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Fate Therapeutics Inc.’s current trading price is -91.94% away from its 52-week high, while its distance from the 52-week low is -5.58%. The stock’s price range during this period has fluctuated between $2.33 and $27.28. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 17.64 million for the day, which was evidently higher than the average daily volume of 2.17 million over the last three months.
Financial Performance and Market Capitalization
Fate Therapeutics Inc. (FATE) has experienced a quarterly decline of -62.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 232.61M and boasts a workforce of 551 employees.
Analysts’ Ratings For Fate Therapeutics Inc.
As of right now, 5 analysts are rating Fate Therapeutics Inc. as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 14 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.40, with a change in price of -4.14. Similarly, Fate Therapeutics Inc. recorded 2,350,860 in trading volume during the last 100 days, posting a change of -65.30%.
FATE Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for FATE stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
FATE Stock Stochastic Average
Fate Therapeutics Inc.’s raw stochastic average for the past 50 days is currently at 2.04%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 7.06%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 6.43% and 12.16%, respectively.
FATE Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease of -78.20%. However, over the past six months, we’ve seen a stronger performance of -60.50%. The price of FATE leaped by -21.15% over the last 30 days. And in the last five days, it has fallen by -11.29%.